Stockscreener 앱 받기
0.6628
17.10%
0.0968
Aethlon Medical Inc 주식(AEMD)의 최신 뉴스
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Aethlon Medical, Inc. Revenue Breakdown – NASDAQ:AEMD - TradingView
AEMD|Aethlon Medical Inc|Price:0.585|Chg%:-0.016 - TradingKey
Aethlon Medical (AEMD) Dips 3.4% to $0.63 as Small-Cap Biotech Faces Persistent Selling PressureIntraday Profile - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Aethlon Medical at emerging growth conference: trial data and cash boost - Investing.com
AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position - TradingView
Aethlon Medical Reports Encouraging Hemopurifier Trial Results - t.co
Aethlon Medical (AEMD) Gains 2.39% as Stock Approaches $0.70 Resistance LevelSentiment Extreme - dars.gov.et
Aethlon Medical reports second cohort results from cancer study - Investing.com UK
Aethlon Medical (AEMD) Slides 5.4% as Pressure Mounts Near Key Support LevelEarnings Beat Stocks - dars.gov.et
Aethlon Medical advances Hemopurifier oncology study to third cohort - grafa.com
Aethlon Medical reports second cohort results from cancer study By Investing.com - Investing.com South Africa
Experimental cancer filter shows repeat immune and tumor-signal shifts in small Australian study - Stock Titan
Aethlon Medical Inc. (AEMD) Q2 2026 Earnings: Narrower Loss Exceeds ExpectationsPretax Income Report - DonanımHaber
Aethlon Medical Announces $4 Million At-the-Market Offering to Advance Cancer and Infectious Disease Therapies - Minichart
Aethlon Medical Announces July 2026 Financing Offering - TipRanks
Aethlon Medical (NASDAQ: AEMD) prices $4M follow-on at-the-market deal - Stock Titan
Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent - TradingView
Aethlon Medical (AEMD) Q1 2025 earnings summary - Quartr
Aethlon Medical (AEMD) launches $0.71 unit offering registering 11.2M shares - Stock Titan
[EFFECT] AETHLON MEDICAL INC SEC Filing - Stock Titan
Aethlon Medical Inc. (AEMD) Slides 7.6% as Shares Approach Key Support LevelSell Signal Alerts - dars.gov.et
AEMDAethlon Medical Inc Latest SEC Filings - Finviz
Aethlon Medical prices $4M follow-on offering at $0.7101 - scanx.trade
Aethlon Medical prices $4M follow-on offering at $0.71 per share - Investing.com
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - TradingView
AEMD Q2 2026 Earnings: EPS Beat Highlights Cost Discipline Amid Pre-Revenue PhaseEarnings Preview - dars.gov.et
AEMD Q2 2026 Earnings: Narrower-than-Expected Loss Highlights Progress in Clinical PipelineSaaS Earnings Trends - DonanımHaber
Form 4 Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax - Stock Titan
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax withholding - Stock Titan
Director at Aethlon Medical (AEMD) forfeits 1,091 shares for tax withholding - Stock Titan
Form S-1/A AETHLON MEDICAL For: 1 July By Investing.com - Investing.com UK
Aethlon Medical (AEMD) updates S-1 with auditor consent, expenses - Stock Titan
Form S-1/A Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (NASDAQ: AEMD) targets $4M unit offering of shares and warrants - Stock Titan
AEMD Q2 2021 Earnings Call - BigGo ファイナンス
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Aethlon Medical (AEMD) Slides 2.22% as Support Level Nears – Key Levels in FocusImbalance Zone - dars.gov.et
Aethlon Medical (AEMD) Reveals Key Research on Long COVID and Ex - GuruFocus
Aethlon Medical study links device to Long COVID markers - Investing.com UK
Aethlon Medical reports two-fold Long COVID signal - grafa.com
Breakthrough Long COVID Biomarker Identified by Aethlon Medical (Nasdaq: AEMD) Opens Door for Hemopurifier Treatment - Investorideas.com
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance - Investorideas.com
Aethlon Medical study links device to Long COVID markers By Investing.com - Investing.com Canada
Aethlon study links Long COVID vesicles to Hemopurifier capture - Stock Titan
Price to sales forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Price to earnings forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Aethlon Medical tracks Ebola outbreak, readies Hemopurifier talks - Stock Titan
Market Movers | Winners: IQST, MEI, ATLN | Losers: NNOX, CRIS, GDC - Trefis
Aethlon Medical, Inc. Actuals & Estimates (NASDAQ:AEMD) - TradingView
Enterprise value to EBIT forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
AEMD Forecast — Price Target — Prediction for 2027 - TradingView
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Amid Pre-Revenue PhaseEarnings Volatility Report - dars.gov.et
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Form S-1 Aethlon Medical Inc For: 22 June By Investing.com - Investing.com Nigeria
Aethlon Medical (AEMD) files S-1 for $12M stock and warrant offering - Stock Titan
Aethlon Medical | S-1: General form for registration of securities under the Securities Act of 1933 - Moomoo
1.04%
11.95%
자본화:
|
볼륨(24시간):